Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype-Reference-Cited by-同舟云学术

Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype

Published:2020-11 Issue:11 Volume:38 Page:2338-2338
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Spence J. David

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference10 articles.

1. 2020 International Society of Hypertension global hypertension practice guidelines;Unger;J Hypertens,2020

2. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies;Williams;Lancet Diabetes Endocrinol,2018

3. Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans;Laffer;J Am Soc Hypertens,2014

4. Amiloride, a specific drug for hypertension in black people with T594M variant?;Baker;Hypertension,2002

5. Hypertension in Blacks: individualized therapy based on renin/aldosterone phenotyping;Spence;Hypertension,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Use of Diuretics;Pediatric Nephrology;2022

2. Stroke Prevention: Little-Known and Neglected Aspects;Cerebrovascular Diseases;2021

3. Clinical Use of Diuretics;Pediatric Nephrology;2021

4. Reply;Journal of Hypertension;2020-11